Pluvicto Experiences?
Started in- had radiation for 42 days, 2019 recurred and had hormone therapy, 2022 metastasized and received eligard and xtendi, 2023 xtendi no longer effective and he was changed to eligard and Lynparza. August 2024, PET scan showed increased cancer so Lynparza was discontinued.
Started in- had radiation for 42 days, 2019 recurred and had hormone therapy, 2022 metastasized and received eligard and xtendi, 2023 xtendi no longer effective and he was changed to eligard and Lynparza. August 2024, PET scan showed increased cancer so Lynparza was discontinued.